GE HealthCare Technologies Inc. $GEHC Holdings Lowered by Rathbones Group PLC

Rathbones Group PLC reduced its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 357,748 shares of the company’s stock after selling 7,597 shares during the period. Rathbones Group PLC’s holdings in GE HealthCare Technologies were worth $25,465,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Laurel Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $26,000. Optima Capital LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter worth approximately $27,000. Godfrey Financial Associates Inc. acquired a new stake in GE HealthCare Technologies in the fourth quarter worth approximately $27,000. Montag A & Associates Inc. boosted its stake in GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on GEHC. Piper Sandler reissued a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. Mizuho decreased their target price on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Zacks Research lowered GE HealthCare Technologies from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 21st. Royal Bank Of Canada assumed coverage on shares of GE HealthCare Technologies in a research report on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 price target on the stock. Finally, HSBC reduced their price objective on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $77.73.

GE HealthCare Technologies Trading Up 2.5%

NASDAQ GEHC opened at $69.73 on Tuesday. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. The stock has a market cap of $31.50 billion, a price-to-earnings ratio of 15.99, a PEG ratio of 1.97 and a beta of 0.72. The firm’s 50 day moving average price is $64.13 and its two-hundred day moving average price is $70.33.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.09. The company had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The company’s revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.06 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.91 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s payout ratio is presently 3.21%.

Insider Buying and Selling

In other GE HealthCare Technologies news, Director Rodney F. Hochman bought 1,618 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the acquisition, the director directly owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This trade represents a ? increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Watkin Phoebe L. Yang purchased 1,000 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 8th. The stock was bought at an average cost of $63.01 per share, with a total value of $63,010.00. Following the completion of the transaction, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. This represents a 7.87% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders acquired 12,618 shares of company stock valued at $805,175. Corporate insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.